{{Rsnum
|rsid=7857345
|Gene=CDKN2BAS
|Chromosome=9
|position=22087474
|Orientation=plus
|GMAF=0.208
|Gene_s=CDKN2B-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 52.3 | 46.2 | 1.5
| HCB | 37.8 | 53.3 | 8.9
| JPT | 60.0 | 28.9 | 11.1
| YRI | 98.4 | 1.6 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 37.8 | 53.3 | 8.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20500804
|Title=Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged &lt;/=70
}}

{{PMID Auto
|PMID=21511257
|Title=The chromosome 9p21 region and myocardial infarction in a European population
}}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}